Navigation Links
Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
Date:11/26/2008

f the transaction the companies will become the sole members of a limited liability company (LLC) whose sole purpose would be to commercialize ZEVALIN in the United States. A Board of Managers comprised of an equal number of members from both companies would be established to govern the LLC. Both parties will equally provide for the future capital requirements of the LLC and share equally in the profits and losses of the LLC. Cell Therapeutics will receive an initial payment of $7.5 million at closing and $7.5 million in early January, in addition up to $15 million product sales milestone payments upon achievement of certain revenue targets. The closing of the joint venture transaction is subject to the satisfaction of certain customary closing conditions, including the consent of Biogen Idec, Inc. to convey the ZEVALIN-related assets to the LLC. CTI and Spectrum currently expect the transaction to close in December 2008.

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM), acted as the exclusive strategic advisor in connection with the transaction.

About ZEVALIN(R)

ZEVALIN(R) (Ibritumomab Tiuxetan) is a form of cancer therapy called radioimmunotherapy and is indicated as part of the ZEVALIN therapeutic regimen for treatment of relapsed or refractory, low-grade or follicular B-cell non- Hodgkin's lymphoma, including patients with rituximab refractory follicular NHL. ZEVALIN is also indicated, under accelerated approval, for the treatment of relapsed or refractory, rituximab-naive, low-grade and follicular NHL based on studies using a surrogate endpoint of overall response rate. It was approved by the FDA in February of 2002 as the first radioimmunotherapeutic agent for the treatment of NHL.

Rare deaths associated with an infusion reaction sympto
'/>"/>

SOURCE Spectrum Pharmaceuticals, Inc.; Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. GEECF: Spectrum Launches Zero Waste Philippines and Gears Towards Cheap Green Energy
2. Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
3. "Brave New Reality" Provides a Wide Spectrum of High Tech News and Easy Science.
4. Spectrum Blue Steel's fresh foreign investment at 18 Billion and the Biosphere process spark attention on a global scale
5. Energetiqs Laser-Driven Light Source Technology Enables Continuous Spectrum Light Sources, from Visible to Deep Ultraviolet
6. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
7. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
8. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
9. Global Experts Explore Entire Spectrum of Aids Vaccine Development
10. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
11. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... July 14, 2014 Throughout this ... across the clinical trials space, representing 38 countries ... series entitled “Optimizing Patient Participation in Clinical Trials. ... off with internationally renowned R&D expert, Ken Getz, ... on Reinventing Drug Development through Patient Centricity. , ...
(Date:7/14/2014)... Mass. , July 14, 2014 Minerva ... the development of new therapies to treat neuropsychiatric diseases ... has been appointed vice president of finance and ... Mr. Ahlholm is a senior executive with more than ... at technology and life science companies. His background includes ...
(Date:7/14/2014)... Mateo, CA (PRWEB) July 14, 2014 ... CONNECT patient registry platform, announced that three ... muscular dystrophies; the Phelan-McDermid Syndrome International Registry; ... Nephrotic Syndrome—have been awarded contracts by the ... of the creation of a new health ...
(Date:7/13/2014)... R.I. (Brown University) -- The discovery 30 years ago ... an explosion of nanotechnology research. Now, there appears to ... from Brown University, Shanxi University and Tsinghua University in ... atoms forms a hollow molecular cage similar to a ... boron cage structurepreviously only a matter of speculationdoes indeed ...
Breaking Biology Technology:Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 5Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 3
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) today announced ... scheduled to present at the Rodman & Renshaw,10th Annual ... Tuesday, November 11th, 2008 at 2:50 p.m. Eastern Time ... 2008 at the,Palace Hotel in New York., The ...
... Driven by the emergence of innovative technologies ... and proteomics, world market for drug discovery ... by 2012. Despite the heavy costs involved ... pharmaceutical research and development are reaching new ...
... of Wisconsin-Madison engineers and physicists have developed a method ... that could lay the foundation for faster flexible electronics. ... electronic devices. Silicon thin films could be the basis ... inducing strain into the silicon increases device speed, yet ...
Cached Biology Technology:Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts 2Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts 3Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts 4Stretching silicon: A new method to measure how strain affects semiconductors 2
(Date:7/14/2014)... of Kansas scientists to the discovery and description of ... collections specimen, which turned out to represent a new genus ... ripidiine wedge beetle from Borneo is discussed in a recent ... . , The holotype male, and only known specimen ... in Borneo but subsequent to this it was transferred among ...
(Date:7/14/2014)... environment manage much better in the struggle for survival ... A world without bees would be a whole lot ... million to 1 billion Danish kroner are earned annually ... and pollinating a wide range of crops from apples ... the world are under pressure from pesticides, mites, viruses, ...
(Date:7/14/2014)... The Roquin protein, discovered in 2005, controls T-cell ... certain mRNAs. In doing so, it helps to ... the body,s own structures that can lead to ... Autoimmune diseases affect between five and ten per ... a result of complex environmental influences when a ...
Breaking Biology News(10 mins):Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 2Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 3Best for bees to be stay-at-homes 2Molecular mechanisms underlying the prevention of autoim-munity by Roquin revealed 2
... Since the 1960s, psychiatrists have been hunting for substances ... high levels to produce the symptoms associated with schizophrenia. ... might be related to the hallucinogens phencyclidine (PCP) or ... of psychotic symptoms in schizophrenia. This "auto-intoxication" hypothesis led ...
... March 14, 2013 In the largest ever ... genetics company, identified 20 new genetic associations for myopia, ... in the study, which was specific to individuals of ... data and survey responses from more than 50,000 23andMe ...
... to feed, some whales throw their jaws wide and engulf ... along with their mouths agape (ram or skim feeding), yet ... whales, mouths to filter nutrition from the ocean: baleen. Alexander ... how the hairy substance actually traps morsels of food. ,The ...
Cached Biology News:The mysterious GRIN3A and the cause of schizophrenia 223andMe identifies multiple genetic factors impacting development of nearsightedness 2Whale's streaming baleen tangles to trap food 2
... Serum; U.S. sourced, ideal for ... quality; Low hemoglobin; Endotoxin: < ... of US origin; U.S. sourced, ... an uncompromising quality. Low hemoglobin ...
Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...
Fetal Calf Serum Replacement (Bistec) serum...
...
Biology Products: